Royalty Pharma PLC (RPRX)

Royalty Pharma PLC

RPRX

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
Viking Global Investors	Equity	10,563,939	$328,855,421	1.04%	-13.47%
Patient Capital Management	Equity	2,972,646	$92,538,459	4.76%	+3.39%

Total Shares Held: 13,536,585

Total Value Reported: $421,393,880

Average Allocation per Portfolio 2.90%

Largest Single Portfolio Allocation: 4.76%

Largest Shareholder: Viking Global Investors

Change in Total Shares Held (Q on Q): -1,546,389

Percentage Change in Shares Held (Q on Q): -10.25%

Number of Current Holders: 2

Number of New Holders (Q on Q): 0

Number of Funds with Additions (Q on Q): 1

Number of Funds with Deductions (Q on Q): 1

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 0